Markus Mayrhofer

Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer

Petersson, Alexandra; Svensson, Maja; Hau, Sofie Olsson; Bergstrom, Rebecka et al.

Part of Scientific Reports, 2025

• DOI for Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer
• Download full text (pdf) of Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer

Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Martling, Anna; Hed Myrberg, Ida; Nilbert, Mef; Grönberg, Henrik et al.

Part of New England Journal of Medicine, p. 1051-1064, 2025

• DOI for Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

De Laere, Bram; Crippa, Alessio; Discacciati, Andrea; Larsson, Berit et al.

Part of Nature Medicine, 2024

• DOI for Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
• Download full text (pdf) of Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors

Öfverholm, Ingegerd; Lin, Yingbo; Mondini, Julia; Hardingz, John et al.

Part of Cancers, 2024

• DOI for Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors
• Download full text (pdf) of Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors

Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma

Öfverholm, Ingegerd; Wallander, Karin; Haglund, Cecilia; Chellappa, Venkatesh et al.

Part of Clinical Cancer Research, p. 2647-2658, 2024

• DOI for Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma

Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer

Petersson, Alexandra; Svensson, Maja; Hau, Sofie Olsson; Bergstrom, Rebecka et al.

Part of Scientific Reports, 2025

• DOI for Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer
• Download full text (pdf) of Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer

Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Martling, Anna; Hed Myrberg, Ida; Nilbert, Mef; Grönberg, Henrik et al.

Part of New England Journal of Medicine, p. 1051-1064, 2025

• DOI for Low-Dose Aspirin for PI3K-Altered Localized Colorectal Cancer

Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

De Laere, Bram; Crippa, Alessio; Discacciati, Andrea; Larsson, Berit et al.

Part of Nature Medicine, 2024

• DOI for Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial
• Download full text (pdf) of Androgen receptor pathway inhibitors and taxanes in metastatic prostate cancer: an outcome-adaptive randomized platform trial

Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors

Öfverholm, Ingegerd; Lin, Yingbo; Mondini, Julia; Hardingz, John et al.

Part of Cancers, 2024

• DOI for Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors
• Download full text (pdf) of Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors

Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma

Öfverholm, Ingegerd; Wallander, Karin; Haglund, Cecilia; Chellappa, Venkatesh et al.

Part of Clinical Cancer Research, p. 2647-2658, 2024

• DOI for Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma

The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden

de Ståhl, Teresita Diaz; Shamikh, Alia; Mayrhofer, Markus; Juhos, Szilvester et al.

Part of Journal of Translational Medicine, 2023

• DOI for The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden
• Download full text (pdf) of The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden

Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

Part of Blood Advances, p. 152-164, 2022

• DOI for Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression
• Download full text (pdf) of Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression

Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Stratmann, Svea; Yones, Sara A.; Mayrhofer, Markus; Norgren, Nina et al.

Part of Blood Advances, p. 900-912, 2021

• DOI for Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets

Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages

Baskaran, Sathishkumar; Mayrhofer, Markus; Göransson Kultima, Hanna; Bergström, Tobias et al.

Part of Neuro-Oncology, p. 1080-1091, 2018

• DOI for Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages
• Download full text (pdf) of Primary glioblastoma cells for precision medicine: a quantitative portrait of genomic (in)stability during the first 30 passages

Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer

Mathot, Lucy; Kundu, Snehangshu; Ljungström, Viktor; Svedlund, Jessica et al.

Part of Cancer Research, p. 1730-1740, 2017

• DOI for Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer

Genetic Heterogeneity in Rhabdomyosarcoma Revealed by SNP Array Analysis

Walther, Charles; Mayrhofer, Markus; Nilsson, Jenny; Hofvander, Jakob et al.

Part of Genes, Chromosomes and Cancer, p. 3-15, 2016

• DOI for Genetic Heterogeneity in Rhabdomyosarcoma Revealed by SNP Array Analysis

Rawcopy: Improved copy number analysis with Affymetrix arrays

Mayrhofer, Markus; Viklund, Björn; Isaksson, Anders

Part of Scientific Reports, 2016

• DOI for Rawcopy: Improved copy number analysis with Affymetrix arrays
• Download full text (pdf) of Rawcopy: Improved copy number analysis with Affymetrix arrays

Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer

Mengelbier, Linda Holmquist; Karlsson, Jenny; Lindgren, David; Valind, Anders et al.

Part of Nature Communications, 2015

• DOI for Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer

Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer

Birgisson, Helgi; Edlund, Karolina; Wallin, Ulrik; Påhlman, Lars et al.

Part of BMC Cancer, 2015

• DOI for Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer
• Download full text (pdf) of Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer

Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis.

Crona, Joakim; Backman, Samuel; Maharjan, Rajani; Mayrhofer, Markus et al.

Part of Clinical Cancer Research, p. 4451-4460, 2015

• DOI for Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis.

Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers

Watkins, Johnathan; Weekes, Daniel; Shah, Vandna; Gazinska, Patrycja et al.

Part of Cancer Discovery, p. 488-505, 2015

• DOI for Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers

1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer

Mayrhofer, Markus; Kultima, Hanna Göransson; Birgisson, Helgi; Sundström, Magnus et al.

Part of BMC Cancer, p. 872, 2014

• DOI for 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
• Download full text (pdf) of 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer

Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue

Mayrhofer, Markus; DiLorenzo, Sebastian; Isaksson, Anders

Part of Genome Biology, 2013

• DOI for Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue
• Download full text (pdf) of Patchwork: allele-specific copy number analysis of whole-genome sequenced tumor tissue

Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

Skírnisdóttir, Ingiridur; Mayrhofer, Markus; Rydåker, Maria; Åkerud, Helena et al.

Part of BMC Cancer, p. 407, 2012

• DOI for Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease
• Download full text (pdf) of Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent disease

Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia

Mansouri, Larry; Gunnarsson, Rebeqa; Sutton, Lesley-Ann; Ameur, Adam et al.

Part of American Journal of Hematology, p. 737-740, 2012

• DOI for Next generation RNA-sequencing in prognostic subsets of chronic lymphocytic leukemia

Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity

Rasmussen, Markus; Sundström, Magnus; Kultima, Hanna Göransson; Botling, Johan et al.

Part of Genome Biology, 2011

• DOI for Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity
• Download full text (pdf) of Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity

Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia

Gunnarsson, Rebeqa; Mansouri, Larry; Isaksson, Anders; Göransson, Hanna et al.

Part of Haematologica, p. 1161-1169, 2011

• DOI for Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia

High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors

Marincevic, Millaray; Cahill, Nicola; Isaksson, Anders; Mansouri, Mahmoud Reza et al.

Part of Haematologica, p. 1519-1525, 2010

• DOI for High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors

Characterization of the RNA content of chromatin

Mondal, Tanmoy; Rasmussen, Markus; Pandey, Gaurav Kumar; Isaksson, Anders et al.

Part of Genome Research, p. 899-907, 2010

• DOI for Characterization of the RNA content of chromatin

Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients

Gunnarsson, R.; Isaksson, Anders; Mansouri, Mahmoud; Göransson, H. et al.

Part of Leukemia, p. 211-215, 2010

• DOI for Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients

Quantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array data

Göransson, Hanna; Edlund, Karolina; Rydåker, Maria; Rasmussen, Markus et al.

Part of PloS one, 2009

• DOI for Quantification of normal cell fraction and copy number neutral LOH in clinical lung cancer samples using SNP array data

Copy Number Analysis of Cancer

Mayrhofer, Markus

2015

• Download full text (pdf) of Copy Number Analysis of Cancer

SUPPLEMENTARY MATERIAL: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2021

SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression

Stratmann, Svea; Yones, Sara A.; Garbulowski, Mateusz; Sun, Jitong et al.

2020

• Download full text (pdf) of SUPPLEMENTAL INFORMATION FOR: Transcriptomic analysis reveals pro-inflammatory signatures associated with acute myeloid leukemia progression